Infertile mice produced sperm and fathered offspring after transplantation of sperm progenitor cells grown in laboratory culture, according to research published in the online edition of Proceedings of the National Academy of Sciences.
Infertile mice produced sperm and fathered offspring after transplantation of sperm progenitor cells grown in laboratory culture, according to research published in the online edition of Proceedings of the National Academy of Sciences.
Researchers successfully developed a culture medium with the precise combination of cellular growth factors needed for spermatogonial stem cells to reproduce themselves outside the body. These stem cells were implanted into infertile mice. The mice produced sperm and fathered offspring genetically related to the donor mice.
If the culture media is manipulated, the researchers may be able to induce spermatogonial cells to develop into sperm cells for the fertilization of eggs, said senior author Ralph L. Brinster, VMD, PhD, of the University of Pennsylvania School of Veterinary Medicine in Philadelphia.
"This finding is likely to be applicable to humans," Dr. Brinster said.
Spermatogonial stem cells could be cultured to increase numbers, frozen, and reimplanted at a later date in those males who lose their fertility from chemotherapy, spinal cord injury, Parkinson's disease, or heart disease.
The research was funded in part by the National Institute of Child Health and Human Development.
AUA, SUFU publish 2024 guideline for idiopathic overactive bladder
April 25th 2024“This brand new guideline offers options for all patients with OAB with a focus on shared decision-making between patients with OAB and clinicians, as well as a personalized, tailored approach to care,” said Cameron and Smith.
Enzalutamide granted approval in EU for nmHSPC
April 24th 2024The approval is supported by data from the phase 3 EMBARK trial, which demonstrated that enzalutamide with or without leuprolide prolonged metastasis-free survival compared with leuprolide alone in patients with high-risk biochemically recurrent nmHSPC.